Phd2 Deficiency Induces Obliterative Vascular Remodeling and Severe Pah Through Nitrative Stress and Caveolin-1 Downregulation

Zhiyu Dai,Maggie M. Zhu,You-Yang Zhao

DOI: https://doi.org/10.1096/fasebj.31.1_supplement.1016.8

2017-01-01

Abstract:Background Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary vascular resistance and progressive vascular remodeling. Our recent study for the first time demonstrated that loss of hypoxia inducible factor (HIF) prolyl‐4 hydroxylase 2 (PHD2) in endothelial cells and bone marrow cells in mice induces severe PAH with obliterative pulmonary vascular remodeling and plexiform‐like lesions recapitulating clinical PAH. Increased oxidative/nitrative stress is a hall marker of clinical PAH and Caveolin‐1 (Cav1) is an important regulator of oxidative/nitrative stress and the pathogenesis of clinical PAH. It is unclear whether Cav1 deficiency and nitrative stress are involved in the pathogenesis of severe PAH in this mouse model. Methods Mice with Tie2 Cre‐mediated disruption of Egln1 (encoding PHD2) ( Egln1 CKO ), Egln1 and Hif2a ( EH2 DKO), and mice with Egln1 disruption and Cav1 transgene (expressing Cav1 in endothelial cells) ( Egln1 CKO/Tg) were generated. Western blotting and immunostaining were performed to quantify nitration stress and Cav1 expression. MnTMPyP (a superoxide scavenger) and Tempol (a radical scavenger) were administrated to Egln1 CKO mice. Right ventricular systolic pressure (RVSP) and RV/(LV+S) ratio, indicator of RV hypertrophy, were measured. Pulmonary vascular remodeling were assessed by histological examination. Echocardiography was used to measure RV and PA function. Results Nitrotyrosine was markedly increased in Egln1 CKO mouse lungs and normalized in EH2 DKO mouse lungs. Both MnTMPyP and Tempol treatment inhibited RVSP increase and RV hypertrophy, and decreased medial thickness and muscularization of distal pulmonary arterials in Egln1 CKO mice. Mechanistically, endothelial Cav1 expression was decreased in Egln1 CKO mouse lungs and normalized in EH2 DKO mice. Restored Cav1 expression in Egln1 CKO /Tg mice inhibited RVSP and RV hypertrophy and resulted in normalization of RV and PA function and pulmonary vascular remodeling. Both pharmacological and genetic approaches promoted survival of Egln1 CKO mice. Conclusion These data show that loss of endothelial PHD2 suppresses Cav1 expression in a HIF‐2α dependent manner. Decrease of Cav1 expression and resultant activation of nitrative stress contribute to the severe vascular remodeling and PAH in Egln1 CKO mice. Thus, targeting nitrative stress and restoring Cav1 expression are potentially effective approaches for treatment of PAH. Support or Funding Information NIH grants R01HL123957, R01HL125350, R01HL133951, and P01HL077806 (Project 3) to Y.Y.Z, AHA postdoctoral fellowship grant 15POST25700124 to Z.D.